Published in Future Virol on November 01, 2009
Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease. Future Microbiol (2013) 1.11
Issues related to recent dengue vaccine development. Trop Med Health (2011) 0.86
The importance of hematopoietic progenitor cells in dengue. Ther Adv Hematol (2012) 0.83
Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome. J Biomed Sci (2013) 0.80
Analysis of dengue infection based on Raman spectroscopy and support vector machine (SVM). Biomed Opt Express (2016) 0.78
Immunologic hypo- or non-responder in natural dengue virus infection. J Biomed Sci (2013) 0.77
Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res (2003) 77.89
Dengue. Lancet (2007) 10.54
Phylogeny of the genus Flavivirus. J Virol (1998) 8.87
Humanized mice in translational biomedical research. Nat Rev Immunol (2007) 8.83
Human skin Langerhans cells are targets of dengue virus infection. Nat Med (2000) 5.74
Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology (1997) 4.88
Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis (2003) 4.29
Dengue virus structural differences that correlate with pathogenesis. J Virol (1999) 4.26
Microevolution and virulence of dengue viruses. Adv Virus Res (2003) 3.41
The computer simulation of RNA folding pathways using a genetic algorithm. J Mol Biol (1995) 3.29
Evolutionary relationships of endemic/epidemic and sylvatic dengue viruses. J Virol (2000) 3.21
Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg (1978) 3.08
Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol (2006) 2.76
Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet (2002) 2.56
Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol (2005) 2.50
The Emperor's New Clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am J Trop Med Hyg (1977) 2.41
Role of RNA structures present at the 3'UTR of dengue virus on translation, RNA synthesis, and viral replication. Virology (2005) 2.21
Differential susceptibility of Aedes aegypti to infection by the American and Southeast Asian genotypes of dengue type 2 virus. Vector Borne Zoonotic Dis (2001) 2.20
Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev (2008) 2.19
Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization. J Clin Microbiol (2007) 2.15
Inferring the rate and time-scale of dengue virus evolution. Mol Biol Evol (2003) 2.11
The history and evolution of human dengue emergence. Adv Virus Res (2008) 2.05
Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking. J Virol (2007) 2.03
American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol (2003) 2.03
Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc (2001) 1.96
Dengue fever in humanized NOD/SCID mice. J Virol (2005) 1.96
Severe dengue epidemics in Sri Lanka, 2003-2006. Emerg Infect Dis (2009) 1.89
Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice. Virology (2007) 1.78
Genetic variation in the 3' non-coding region of dengue viruses. Virology (2001) 1.71
Detection of dengue virus replication in peripheral blood mononuclear cells from dengue virus type 2-infected patients by a reverse transcription-real-time PCR assay. J Clin Microbiol (2002) 1.71
Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J Virol (2008) 1.65
Mouse models of dengue virus infection and disease. Antiviral Res (2008) 1.56
Genome cyclization as strategy for flavivirus RNA replication. Virus Res (2008) 1.54
Humanized SCID mouse models for biomedical research. Curr Top Microbiol Immunol (2008) 1.48
A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections. J Immunol (2008) 1.48
Genetic variation among dengue 2 viruses of different geographic origin. Virology (1983) 1.48
Functional analysis of dengue virus cyclization sequences located at the 5' and 3'UTRs. Virology (2008) 1.47
Human genetic determinants of dengue virus susceptibility. Microbes Infect (2008) 1.46
Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys. J Infect Dis (2005) 1.43
RNA secondary structure in the coding region of dengue virus type 2 directs translation start codon selection and is required for viral replication. J Virol (2006) 1.38
Differential effects of dengue virus on infected and bystander dendritic cells. J Virol (2005) 1.33
Enumeration of an extremely high particle-to-PFU ratio for Varicella-zoster virus. J Virol (2009) 1.33
Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein. Am J Trop Med Hyg (2001) 1.30
Molecular and in vitro analysis of eight dengue type 2 viruses isolated from patients exhibiting different disease severities. Virology (1998) 1.29
Poly(A)-binding protein binds to the non-polyadenylated 3' untranslated region of dengue virus and modulates translation efficiency. J Gen Virol (2009) 1.25
RNA fingerprinting as a method for distinguishing dengue 1 virus strains. Am J Trop Med Hyg (1983) 1.25
An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies. J Virol Methods (2006) 1.22
Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology (2008) 1.20
Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice. PLoS One (2008) 1.20
Models of dengue virus infection. Drug Discov Today Dis Models (2006) 1.18
In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J Virol Methods (2004) 1.11
Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers. J Med Virol (2003) 1.11
Specific requirements for elements of the 5' and 3' terminal regions in flavivirus RNA synthesis and viral replication. Virology (2008) 1.11
Expanded CD34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rgamma(null) mice. Exp Biol Med (Maywood) (2008) 1.10
Advances in RNA structure prediction from sequence: new tools for generating hypotheses about viral RNA structure-function relationships. J Virol (2009) 1.09
Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies. Am J Trop Med Hyg (2008) 1.07
TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. J Infect Dis (2009) 1.06
Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains. Virology (2008) 1.04
Establishing humanized mice using stem cells: maximizing the potential. Clin Exp Immunol (2008) 0.97
A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J Leukoc Biol (2006) 0.95
Combination of CTLA-4 and TGFbeta1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak. Clin Immunol (2009) 0.92
CD40 ligand enhances dengue viral infection of dendritic cells: a possible mechanism for T cell-mediated immunopathology. J Immunol (2006) 0.91
Difference between the abilities of human Fcgamma receptor-expressing CV-1 cells to neutralize American and Asian genotypes of dengue virus 2. Clin Vaccine Immunol (2008) 0.88
Comparative analysis reveals no consistent association between the secondary structure of the 3'-untranslated region of dengue viruses and disease syndrome. J Gen Virol (2006) 0.88
Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection. J Med Virol (2009) 0.84
An improved endothelial barrier model to investigate dengue haemorrhagic fever. J Virol Methods (2002) 0.82
RNA secondary structures in the proximal 3'UTR of Indonesian Dengue 1 virus strains. Virus Res (2009) 0.76